Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
Open Access
- 12 September 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (6), 705-709
- https://doi.org/10.1038/sj.bjc.6603328
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality ParadigmJournal of Clinical Oncology, 2006
- Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the EsophagusJournal of Clinical Oncology, 2005
- Esophageal CancerThe New England Journal of Medicine, 2003
- Phase I Trial of Escalating-Dose Irinotecan Given Weekly With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal CancerJournal of Clinical Oncology, 2003
- CPT‐11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinomaCancer, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor XenograftsJapanese Journal of Cancer Research, 1997
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusThe New England Journal of Medicine, 1992
- Application of the triangular test to phase II cancer clinical trialsStatistics in Medicine, 1990
- Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.Gut, 1982